Zensar Technologies: Bridgeview Life Sciences Merger Effective August 1

Zensar Technologies Ltd announced that the merger of its US-based wholly owned subsidiary, Bridgeview Life Sciences LLC, with Zensar Technologies Inc., USA, will be effective from August 1, 2026. All necessary filings with relevant local authorities and state agencies for this merger were completed on July 30, 2026. The company had previously granted in-principle approval for this merger, along with M3BI LLC, on July 29, 2026. Filings for the merger of M3BI LLC are still in progress. This update follows their earlier communication regarding the board's in-principle approval.